1. Home
  2. SNDX vs SPH Comparison

SNDX vs SPH Comparison

Compare SNDX & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • SPH
  • Stock Information
  • Founded
  • SNDX 2005
  • SPH 1945
  • Country
  • SNDX United States
  • SPH United States
  • Employees
  • SNDX N/A
  • SPH N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • SPH Other Specialty Stores
  • Sector
  • SNDX Health Care
  • SPH Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • SPH Nasdaq
  • Market Cap
  • SNDX 1.2B
  • SPH 1.2B
  • IPO Year
  • SNDX 2016
  • SPH 1996
  • Fundamental
  • Price
  • SNDX $14.34
  • SPH $21.84
  • Analyst Decision
  • SNDX Strong Buy
  • SPH Hold
  • Analyst Count
  • SNDX 10
  • SPH 3
  • Target Price
  • SNDX $36.20
  • SPH $19.67
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • SPH 303.8K
  • Earning Date
  • SNDX 02-25-2025
  • SPH 02-06-2025
  • Dividend Yield
  • SNDX N/A
  • SPH 5.98%
  • EPS Growth
  • SNDX N/A
  • SPH N/A
  • EPS
  • SNDX N/A
  • SPH 1.14
  • Revenue
  • SNDX $16,000,000.00
  • SPH $1,327,172,000.00
  • Revenue This Year
  • SNDX N/A
  • SPH N/A
  • Revenue Next Year
  • SNDX N/A
  • SPH N/A
  • P/E Ratio
  • SNDX N/A
  • SPH $19.07
  • Revenue Growth
  • SNDX N/A
  • SPH N/A
  • 52 Week Low
  • SNDX $12.06
  • SPH $15.20
  • 52 Week High
  • SNDX $25.34
  • SPH $21.79
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 54.69
  • SPH 76.49
  • Support Level
  • SNDX $13.97
  • SPH $19.57
  • Resistance Level
  • SNDX $13.16
  • SPH $21.49
  • Average True Range (ATR)
  • SNDX 0.66
  • SPH 0.84
  • MACD
  • SNDX 0.17
  • SPH 0.27
  • Stochastic Oscillator
  • SNDX 85.39
  • SPH 98.79

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About SPH Suburban Propane Partners L.P.

Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.

Share on Social Networks: